Against pragmatism: on efficacy, effectiveness and the real world
Open Access
- 6 July 2009
- journal article
- Published by Springer Science and Business Media LLC in Trials
- Vol. 10 (1), 48
- https://doi.org/10.1186/1745-6215-10-48
Abstract
Explanatory and pragmatic trials represent ends of a continuum of attitudes about clinical trial design. Recent literature argues that pragmatic trials are more informative about clinical care in the real world. Although there is place for more pragmatic studies to inform clinical practice and health policy decision-making, we are concerned that it is generally under-appreciated that extrapolating the results of broadly inclusive pragmatic trials to the care of real patients may often be as problematic as extrapolating the results of narrowly focused explanatory or efficacy trials. Simplistic interpretation of pragmatic trials runs the risk of driving harmful policies.Keywords
This publication has 10 references indexed in Scilit:
- Making trials matter: pragmatic and explanatory trials and the problem of applicabilityTrials, 2009
- Competing risk and heterogeneity of treatment effect in clinical trialsTrials, 2008
- Limitations of Applying Summary Results of Clinical Trials to Individual PatientsJAMA, 2007
- Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysisBMC Medical Research Methodology, 2006
- From subgroups to individuals: general principles and the example of carotid endarterectomyThe Lancet, 2005
- From subgroups to individuals: general principles and the example of carotid endarterectomyThe Lancet, 2005
- Practical Clinical TrialsPublished by American Medical Association (AMA) ,2003
- Prediction of benefit from carotid endar terectomy in individual patients: a risk-modelling studyThe Lancet, 1999
- The Highest Attainable Standard: Ethical Issues in AIDS VaccinesScience, 1998
- Can overall results of clinical trials be applied to all patients?The Lancet, 1995